HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Annette Champion Selected Research

trandolapril (Mavik)

8/2010Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
11/2009INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.
6/2009Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
4/2009Characteristics and outcomes of revascularized patients with hypertension: an international verapamil SR-trandolapril substudy.
3/2009Risk factor assessment for new onset diabetes: literature review.
10/2008Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.
8/2008Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
5/2008Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST).
2/2008Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
1/2008Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Annette Champion Research Topics

Disease

8Coronary Artery Disease (Coronary Atherosclerosis)
08/2010 - 01/2007
6Hypertension (High Blood Pressure)
11/2009 - 01/2007
5Stroke (Strokes)
08/2010 - 01/2007
4Myocardial Infarction
08/2010 - 01/2007
2Insulin Resistance
03/2009 - 01/2008
1Abdominal Obesity
03/2009
1Type 2 Diabetes Mellitus (MODY)
03/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2009
1Albuminuria
10/2008
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2008
1Proteinuria
10/2008
1Angina Pectoris
08/2008
1Glucose Intolerance
01/2008
1Cardiovascular Diseases (Cardiovascular Disease)
10/2007
1Obesity
10/2007
1Heart Failure
10/2007

Drug/Important Bio-Agent (IBA)

12trandolapril (Mavik)FDA LinkGeneric
08/2010 - 01/2007
12Verapamil (Calan)FDA LinkGeneric
08/2010 - 01/2007
9Atenolol (Tenormin)FDA LinkGeneric
08/2010 - 01/2007
5Hydrochlorothiazide (Esidrix)FDA LinkGeneric
11/2009 - 01/2007
2Antihypertensive Agents (Antihypertensives)IBA
06/2009 - 10/2008
2Glucose (Dextrose)FDA LinkGeneric
03/2009 - 01/2008
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2008 - 01/2007
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
10/2008 - 01/2007
1CalciumIBA
11/2009
1Losartan (Cozaar)FDA LinkGeneric
03/2009
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
03/2009
11,4-dihydropyridine (dihydropyridine)IBA
10/2008
1benazepril (Briem)FDA LinkGeneric
10/2008
1Amlodipine (Norvasc)FDA LinkGeneric
10/2008
1Angiotensin Receptor AntagonistsIBA
10/2008
1DiureticsIBA
01/2008

Therapy/Procedure

1Percutaneous Coronary Intervention
10/2007
1Therapeutics
01/2007